![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Drug Research
Titan Pharmaceuticals Receives Fda Communication On Ropinirole Implant Investigational New Drug Application
Titan Pharmaceuticals, Inc ,a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery platform announced...
Clinical Trials
Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases
Inovio Pharmaceuticals, Inc. announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (GLS-5300) and Zika...
Press Releases
Novartis drug Zykadia receives FDA Priority Review for first-line use in patients with ALK+ metastatic NSCLC
Novartis announced that the US FDA accepted the Company's supplemental New Drug Application (sNDA) for filing, and granted Priority Review for the expanded use...
Production & Manufacturing
Johnson Matthey and Rennovia announce licence agreement with ADM for glucaric acid production technology
Johnson Matthey, a global specialty chemicals company and provider of advanced process technologies, and Rennovia Inc., a privately held company that develops novel catalysts...
Press Releases
Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To Introduce New Line Of Products
Valeant Pharmaceuticals International, Inc.'s wholly owned subsidiary Obagi Medical Products, a long-time leader in professional skin care announced a collaboration with Nextcell Medical Company...
Packaging & Labelling
Videojet introduces new pink UV fluorescent ink to drive productivity
Fluorescing UV inks offer a number of advantages, including high print quality, improved durability and enhanced productivity. Fluorescing UV ink is...
News
eRegulatory Summit – Expert Speaker Post
Join the experts at this year's eRegulatory Summit for all the latest industry updates, regulatory advice, practical guidance & ample case studies for benchmarking...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read